Target intelligence / Profile preview

Hepatitis B Virus Antigens (HBV Antigens)

Target
HBV Antigens
Molecular classification
Viral protein
01

Overview

Hepatitis B virus (HBV) antigens, including HBsAg, HBcAg, and HBx, are viral proteins expressed during HBV infection. They serve as targets for immunotherapeutic strategies aimed at clearing the virus and treating HBV-related diseases, such as chronic hepatitis B and hepatocellular carcinoma. These antigens are recognized by the immune system, particularly T cells, which can be engineered to specifically target and eliminate HBV-infected cells.

Other names
Hepatitis B Surface AntigenHBsAgHepatitis B Core AntigenHBcAgHepatitis B X AntigenHBx
02

Mechanism of action

Targeted destruction of HBV-infected cells via T cell-mediated cytotoxicity

03

Biological functions

Viral replicationImmune evasionHepatocyte interaction
04

Disease associations

Chronic Hepatitis B infectionHepatocellular carcinomaLiver cirrhosis
05

Safety considerations

HLA restriction of TCR-based therapiesT cell exhaustionOff-target effects of engineered T cellsCytokine release syndrome
06

Interacting drugs

Anti-HBs antibodies

2 more in the full profile.

07

Biomarkers

HBsAg levelsHBcAg levelsHBx levelsHLA-A2 statusHBcore169-specific CD8+ T cell frequencyTOX expressionPD-1 expression

Beyond the preview

Go deeper on Hepatitis B Virus Antigens (HBV Antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B Virus Antigens (HBV Antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call